This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of medical advice or treatment from a personal physician. All viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. Neither Dr. Axe nor the publisher of this content takes responsibility for possible health consequences of any person or persons reading or following the information in this educational content. All viewers of this content, especially those taking prescription or over-the-counter medications, should consult their physicians before beginning any nutrition, supplement or lifestyle program.
To be clear, there is no one specific test, scan, or anything else of the sort that you can do to determine whether or not you need CBD oil for pain. Also, since cannabis is not yet recognized by the FDA, you unfortunately can’t really go to your doctor either and have them recommend it; until marijuana is FDA-approved, it cannot be prescribed by physicians.
Zynerba is no longer pursuing a version of that drug for osteoarthritis, says Dr. Clauw, and there are currently no standard recommendations for what dosage or formulation of CBD (in either oral or topical form) might work best for pain relief. But he does want pain patients to know that CBD products may be worth a try—and that they may provide relief, even without the high that products with THC produce.
Hemp-derived CBD oil products were made federally legal in December 2018 with the signing of the 2018 Farm Bill. However, several states still have laws in place that restrict the sale and possession of these products. While most companies selling CBD oil are shipping to all 50 states, you should consult your local laws or an attorney in your area if you have concerns about legalities.

Zuardi, A. W., Crippa, J. A., Hallak, J. E., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., … & Guimarães, F. S. (2012). A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation [Abstract]. Current Pharmaceutical Design, 18(32), 5,131–5,140. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22716160

×